February 18, 2021
HADLIMA® (adalimumab injection) Now Available for the Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Adult Crohn’s Disease, Ulcerative Colitis, Hidradenitis Suppurativa, Plaque Psoriasis, Adult and Pediatric Uveitiss and men 9 - 45 years of age
This website is designed to provide members of the media with quick and easy access to recent information about Merck. For additional information, please visit 'About Merck'.
For journalists with a media inquiry, please contact us: 1-833-90MERCK (1-833-906-3725).